相似文献
1
Hemoglobin-based red blood cell substitutes and nitric oxide.
Trends Cardiovasc Med. 2009 Apr;19(3):103-7. doi: 10.1016/j.tcm.2009.06.004.
2
Endothelial dysfunction enhances vasoconstriction due to scavenging of nitric oxide by a hemoglobin-based oxygen carrier.
Anesthesiology. 2010 Mar;112(3):586-94. doi: 10.1097/ALN.0b013e3181cd7838.
3
Normalization of hemoglobin-based oxygen carrier-201 induced vasoconstriction: targeting nitric oxide and endothelin.
J Appl Physiol (1985). 2017 May 1;122(5):1227-1237. doi: 10.1152/japplphysiol.00677.2016. Epub 2017 Feb 9.
4
Inhaled nitric oxide enables artificial blood transfusion without hypertension.
Circulation. 2008 Apr 15;117(15):1982-90. doi: 10.1161/CIRCULATIONAHA.107.729137. Epub 2008 Apr 7.
5
Mixed S-nitrosylated polymerized bovine hemoglobin species moderate hemodynamic effects in acutely hypoxic rats.
Am J Respir Cell Mol Biol. 2010 Feb;42(2):200-9. doi: 10.1165/rcmb.2008-0364OC. Epub 2009 Apr 24.
6
Inhaled nitric oxide prevents systemic and pulmonary vasoconstriction due to hemoglobin-based oxygen carrier infusion: A case report.
J Crit Care. 2019 Jun;51:213-216. doi: 10.1016/j.jcrc.2018.04.008. Epub 2019 Jan 30.
7
Resuscitation with a blood substitute causes vasoconstriction without nitric oxide scavenging in a model of arterial hemorrhage.
J Am Coll Surg. 2004 Nov;199(5):693-701. doi: 10.1016/j.jamcollsurg.2004.07.025.
8
Prevention of the pulmonary vasoconstrictor effects of HBOC-201 in awake lambs by continuously breathing nitric oxide.
Anesthesiology. 2009 Jan;110(1):113-22. doi: 10.1097/ALN.0b013e318190bc4f.
9
Differential sensitivities of pulmonary and coronary arteries to hemoglobin-based oxygen carriers and nitrovasodilators: study in a bovine ex vivo model of vascular strips.
Vascul Pharmacol. 2010 May-Jun;52(5-6):215-23. doi: 10.1016/j.vph.2009.12.005. Epub 2009 Dec 22.
10
Nitroglycerin attenuates vasoconstriction of HBOC-201 during hemorrhagic shock resuscitation.
Resuscitation. 2010 Apr;81(4):481-7. doi: 10.1016/j.resuscitation.2009.12.015. Epub 2010 Jan 18.
引用本文的文献
1
How Nitric Oxide Hindered the Search for Hemoglobin-Based Oxygen Carriers as Human Blood Substitutes.
Int J Mol Sci. 2023 Oct 4;24(19):14902. doi: 10.3390/ijms241914902.
2
Structural optimization and prospect of constructing hemoglobin oxygen carriers based on hemoglobin.
Heliyon. 2023 Aug 29;9(9):e19430. doi: 10.1016/j.heliyon.2023.e19430. eCollection 2023 Sep.
3
Model-based evaluation of the microhemodynamic effects of PEGylated HBOC molecules in the rat brain cortex: a laser speckle imaging study.
Biomed Opt Express. 2020 Jul 9;11(8):4150-4175. doi: 10.1364/BOE.388089. eCollection 2020 Aug 1.
4
Inhaled nitric oxide prevents systemic and pulmonary vasoconstriction due to hemoglobin-based oxygen carrier infusion: A case report.
J Crit Care. 2019 Jun;51:213-216. doi: 10.1016/j.jcrc.2018.04.008. Epub 2019 Jan 30.
5
Inhaled nitric oxide.
Br J Pharmacol. 2019 Jan;176(2):246-255. doi: 10.1111/bph.14512. Epub 2018 Nov 16.
6
Pulmonary Delivery of Therapeutic and Diagnostic Gases.
J Aerosol Med Pulm Drug Deliv. 2018 Apr;31(2):78-87. doi: 10.1089/jamp.2017.1431. Epub 2018 Feb 16.
7
Artificial Blood for Dogs.
Sci Rep. 2016 Nov 10;6:36782. doi: 10.1038/srep36782.
8
Acute kidney function and morphology following topload administration of recombinant hemoglobin solution.
Artif Cells Nanomed Biotechnol. 2017 Feb;45(1):24-30. doi: 10.1080/21691401.2016.1241795. Epub 2016 Oct 31.
9
Hemoglobin βCys93 is essential for cardiovascular function and integrated response to hypoxia.
Proc Natl Acad Sci U S A. 2015 May 19;112(20):6425-30. doi: 10.1073/pnas.1502285112. Epub 2015 Mar 25.
10
Inhaled nitric oxide attenuates the adverse effects of transfusing stored syngeneic erythrocytes in mice with endothelial dysfunction after hemorrhagic shock.
Anesthesiology. 2012 Dec;117(6):1190-202. doi: 10.1097/ALN.0b013e318272d866.
本文引用的文献
1
Haemodynamic effects, safety, and tolerability of haemoglobin-based oxygen carrier-201 in patients undergoing PCI for CAD.
EuroIntervention. 2008 Mar;3(5):600-9. doi: 10.4244/eijv3i5a108.
2
Nanobiotechnology for hemoglobin-based blood substitutes.
Crit Care Clin. 2009 Apr;25(2):373-82, Table of Contents. doi: 10.1016/j.ccc.2008.12.006.
3
Human polymerized hemoglobin for the treatment of hemorrhagic shock when blood is unavailable: the USA multicenter trial.
J Am Coll Surg. 2009 Jan;208(1):1-13. doi: 10.1016/j.jamcollsurg.2008.09.023. Epub 2008 Nov 7.
4
Pulmonary vasodilator responses to sodium nitrite are mediated by an allopurinol-sensitive mechanism in the rat.
Am J Physiol Heart Circ Physiol. 2009 Feb;296(2):H524-33. doi: 10.1152/ajpheart.00543.2008. Epub 2008 Dec 12.
5
Brief periods of nitric oxide inhalation protect against myocardial ischemia-reperfusion injury.
Anesthesiology. 2008 Oct;109(4):675-82. doi: 10.1097/ALN.0b013e318186316e.
6
Cell-free hemoglobin-based blood substitutes and risk of myocardial infarction and death: a meta-analysis.
JAMA. 2008 May 21;299(19):2304-12. doi: 10.1001/jama.299.19.jrv80007. Epub 2008 Apr 28.
7
Sickle cell disease vasculopathy: a state of nitric oxide resistance.
Free Radic Biol Med. 2008 Apr 15;44(8):1506-28. doi: 10.1016/j.freeradbiomed.2008.01.008. Epub 2008 Jan 26.
8
The nitrate-nitrite-nitric oxide pathway in physiology and therapeutics.
Nat Rev Drug Discov. 2008 Feb;7(2):156-67. doi: 10.1038/nrd2466.
9
Haemoglobin-vesicles as artificial oxygen carriers: present situation and future visions.
J Intern Med. 2008 Jan;263(1):4-15. doi: 10.1111/j.1365-2796.2007.01893.x. Epub 2007 Nov 27.
10
Resuscitation with recombinant hemoglobin rHb2.0 in a rodent model of hemorrhagic shock.
Anesthesiology. 2007 Aug;107(2):273-80. doi: 10.1097/01.anes.0000270756.11669.64.
Zotero 插件